NextCure (NXTC) Earnings
Price: $0.46
Market Cap: $12.88M
Market Cap: $12.88M
Revenue (TTM): $-
Net Income: $-55.65M
Net Income: $-55.65M
P/E Ratio: -0.23
EPS (TTM): $-1.99
EPS (TTM): $-1.99
Earnings Dates
NextCure (NXTC) reports its earnings quarterly. Here are the key details:
Next Earnings Date
- Date: May 01, 2025
- Time of Day: Before Market Open
- Estimated EPS: $-0.4
Last Earnings Report
- Date: March 06, 2025
- EPS: $-0.41
- EPS Estimate: $-0.34
NextCure's next earnings report is scheduled for May 01, 2025.
In its last earnings report on March 06, 2025, NextCure reported earnings per share (EPS) of $-0.41, compared to an estimated EPS of $-0.34. The company reported revenue of $-, compared to an estimated revenue of $-.
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|
Earnings History
| Date | EPS | EPS Estimate | Revenue | Revenue Estimate |
|---|---|---|---|---|
| March 06, 2025 | $-0.41 | $-0.34 | $- | $- |
| November 07, 2024 | $-0.41 | $-0.35 | $- | $- |
| August 01, 2024 | $-0.55 | $-0.36 | $- | $- |
| May 02, 2024 | $-0.61 | $-0.45 | $- | $- |
| March 21, 2024 | $-0.52 | $-0.54 | $6.28M | $- |
| November 02, 2023 | $-0.51 | $-0.64 | $- | $- |
| August 03, 2023 | $-0.64 | $-0.60 | $- | $- |
| May 04, 2023 | $-0.58 | $-0.64 | $- | $- |
| March 02, 2023 | $-0.62 | $-0.65 | $- | $- |
| November 03, 2022 | $-0.68 | $-0.60 | $- | $- |
| August 04, 2022 | $-0.65 | $-0.73 | $- | $- |
| May 05, 2022 | $-0.74 | $-0.68 | $- | $- |
| March 03, 2022 | $-0.61 | $-0.67 | $- | $- |
| November 04, 2021 | $-0.65 | $-0.67 | $- | $- |
| August 05, 2021 | $-0.65 | $-0.60 | $- | $- |
| May 06, 2021 | $-0.60 | $-0.57 | $- | $- |
| March 04, 2021 | $-0.56 | $-0.58 | $0 | $- |
Annual Earnings
Annual Revenue
$-
Fiscal Year 2024Annual Net Income
$-55.65M
Fiscal Year 2024Annual EPS
$-1.99
Fiscal Year 2024Quarterly Earnings
Revenue
$-
Quarter Ending December 31, 2024Net Income
$-11.60M
Quarter Ending December 31, 2024EPS
$-0.41
Quarter Ending December 31, 2024Earnings Metrics
Earnings Yield
-258.13%
Year Ending December 31, 2024P/E Ratio
-0.39
Year Ending December 31, 2024Revenue Per Share
$0.00
Year Ending December 31, 2024Earnings Yield (TTM)
-432.47%
Trailing Twelve MonthsP/E Ratio (TTM)
-0.23
Trailing Twelve MonthsRevenue Per Share (TTM)
$0.00
Trailing Twelve MonthsFrequently Asked Questions
NextCure's next earnings date is scheduled for May 01, 2025. The earnings call is expected to take place before market open.
In its last earnings report on March 06, 2025, NextCure reported earnings per share (EPS) of $-0.41, compared to an estimated EPS of $-0.34. The company reported revenue of $-, compared to an estimated revenue of $-.
NextCure's current Price-to-Earnings (P/E) ratio is -0.39. The trailing twelve months (TTM) P/E ratio is -0.23. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.
For the fiscal year ending December 31, 2024, NextCure reported total revenue of $- and net income of $-55.65M. This represents a net profit margin of None.
NextCure's earnings yield is -258.13%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.
NextCure's return on equity (ROE) is -85.00%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.
NextCure's gross profit margin is 0.00%. This indicates that for every dollar of revenue, the company retains $0.00 as gross profit after accounting for the cost of goods sold.